As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospec | Sanofi has reported mixed phase 3 data ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Continued inventory correction for Syngene’s largest commercial biologics product drags earnings for a second straight ...

A team from Würzburg has fundamentally changed our understanding of platelet biology. The researchers demonstrate that the ...

As of Friday, January 23, Tectonic Therapeutic, Inc.’s TECX share price has surged by 6.09%, which has investors questioning ...

Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U ...

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in obesity, with some also earmarked for two other programmes – an ...

Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 6, 2026, to report its financial results for the second quarter ended ...

Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...